Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance of Humira Injection in Korean JIA Patients Under the New-Drug Re-examination

NCT02141984 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02141984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02141984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance of Humira Injection in Korean JIA Patients Under the New-Drug Re-examination
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
April 30, 2016
Enrollment
28 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

polyarticular juvenile idiopathic arthritis